Pipeline
Preclin. Phase I Phase II Phase III Registr.
Registration application
LAS41002
Topical anti-inflamatory
Registration application in EU
LAS 41002: Topical anti-inflammatory agent for the treatment of eczema, which is in clinical phase III in comparison studies with Ecural. LAS41002 acts on a corticosteroid receptor and its different formulations will allow treatment of different skin conditions. 
LAS41004
Combination
2014
LAS41004: This compound is in phase II, the goal is to confirm its anti-inflammatory activity and its capacity to inhibit cellular proliferation through topical administration for the treatment of psoriasis and/or atopic dermatitis.
LAS41007
(Undisclosed)
2012
print 
Start of page